학술논문
Intratumoral delivery of TransCon™ TLR7/8 Agonist promotes sustained anti-tumor activity and local immune cell activation while minimizing systemic cytokine induction
Document Type
Article
Author
Zúñiga, L.A.; Uppal, K.; Hong, E.; Bang, K.; Thakar, D.; Lee, Y.-C.; Martinez, S.; Sabharwal, S.S.; Tabrizifard, M.; Mirza, A.M.; Rosen, D.B.; Punnonen, J.; Leßmann, T.; Bisek, N.; Zettler, J.; Stark, S.; Faltinger, F.; Kracker, O.; Weisbrod, S.; Müller, R.; Voigt, T.; Bigott, K.; Rasmussen, C.E.; Karlsson, J.-J.; Holten-Andersen, L.; Breinholt, V.M.; Sprogøe, K.
Source
In: Cancer Cell International . (Cancer Cell International, December 2022, 22(1))
Subject
Language
English
ISSN
14752867